In this webinar, you’ll hear how automated liquid handling for LC-MS/MS sample preparation contributed to the identification and quantification of over 30 metabolites that can predict adverse pregnancy outcomes, including pre-eclampsia.

In this webinar, our speaker will discuss the role of glucosyl and galactosyl ceramides as biomarkers and how their misregulation can be an identifier for various disease states including, but not limited to, Parkinson’s, Krabbe and Gaucher diseases.

An incredible opportunity to ask the Chief Editor of Nature on how to get published in high-ranking journals.

In this webinar, our expert speaker will discuss how to optimize your untargeted approaches on Zeno SWATH DIA using a modular workflow. With this approach, each subset of the full mass range can be individually adjusted to meet project-specific and user-defined goals, enhancing the performance and adaptability of untargeted MS tools for exposomics research.

Using the example of tumor-associated macrophages (TAMs), this webinar takes a closer look at immune cells in the tumor microenvironment (TME), helping us to gain a better understanding of how specific subtypes and their reprogramming may influence therapy efficiency.

Dr. Walker will discuss how he integrates proteomic, genetic, brain imaging and cerebral spinal fluid biomarkers from initially cognitively normal individuals who later develop dementia, in order to discover novel blood-based biomarkers and mechanistically relevant proteins for therapeutic target prioritization.